These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 32411773)
1. Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model. Sun L; Zhang Z; Yao Y; Li WY; Gu J Ann Transl Med; 2020 Apr; 8(8):550. PubMed ID: 32411773 [TBL] [Abstract][Full Text] [Related]
2. A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases. Yang D; Ma X; Song P Sci Rep; 2022 Jan; 12(1):437. PubMed ID: 35013450 [TBL] [Abstract][Full Text] [Related]
3. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
4. Identification and development of an independent immune-related genes prognostic model for breast cancer. Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008 [TBL] [Abstract][Full Text] [Related]
5. Construction of an immune-related gene prognostic model with experimental validation and analysis of immune cell infiltration in lung adenocarcinoma. Yang J; Tang C; Li C; Li X; Yang W Oncol Lett; 2024 Jul; 28(1):297. PubMed ID: 38751753 [TBL] [Abstract][Full Text] [Related]
6. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling. Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics. Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645 [TBL] [Abstract][Full Text] [Related]
8. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration. Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer. Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ Am J Transl Res; 2020; 12(9):5844-5865. PubMed ID: 33042464 [TBL] [Abstract][Full Text] [Related]
10. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
11. Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment. Zhou J; Shi S; Qiu Y; Jin Z; Yu W; Xie R; Zhang H Front Pharmacol; 2023; 14():1153565. PubMed ID: 37077811 [No Abstract] [Full Text] [Related]
12. Screening of prognostic immune genes and establishment of prognostic model of cervical adenocarcinoma based on bioinformatics analysis. Yi Y; Sheng J; Nie J Ann Transl Med; 2022 May; 10(10):548. PubMed ID: 35722389 [TBL] [Abstract][Full Text] [Related]
13. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer. Tian WJ; Liu SS; Li BR Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells. Zhang Y; He RQ; Dang YW; Zhang XL; Wang X; Huang SN; Huang WT; Jiang MT; Gan XN; Xie Y; Li P; Luo DZ; Chen G; Gan TQ Cancer Cell Int; 2016; 16():89. PubMed ID: 27980454 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the tumor immune environment identifies an immune gene set-based prognostic signature in non-small cell lung cancer. Guo G; Yang L; Wen Y; Wang G; Zhang R; Zhao D; Huang Z; Zhang X; Lin Y; Zhang L Ann Transl Med; 2022 Jan; 10(1):15. PubMed ID: 35242860 [TBL] [Abstract][Full Text] [Related]
16. Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer. Yang Y; Lu S; Gu G Heliyon; 2024 Sep; 10(17):e36816. PubMed ID: 39286099 [TBL] [Abstract][Full Text] [Related]
17. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values. Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis. Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197 [TBL] [Abstract][Full Text] [Related]
20. Using Machine Learning Modeling to Explore New Immune-Related Prognostic Markers in Non-Small Cell Lung Cancer. Xu J; Nie H; He J; Wang X; Liao K; Tu L; Xiong Z Front Oncol; 2020; 10():550002. PubMed ID: 33215029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]